FIELD: medicine, pharmacy. SUBSTANCE: invention describes the single pharmaceutical medicinal formulation, as such, tablet or capsule comprising the effective dose of tibolon being usually from 0.01% to 10% by weight and pharmaceutically acceptable carrier containing starch in the amount from 10% to 100% by weight. Invention provides the preparing the more stable tibolon formulation providing storage under dry condition and decrease of the dose of active component. EFFECT: improved properties of composition. 11 cl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING DOSING UNITS BY WET GRANULATION METHOD | 1995 |
|
RU2166936C2 |
SOLID PHARMACEUTICAL COMPOSITION AND METHOD OF ITS PREPARING | 1995 |
|
RU2152802C2 |
COMPACTED DESOGOSTREL TABLETS, PREPARATION THEREOF BY DRY GRANULATION TECHNIQUE | 1996 |
|
RU2159618C2 |
TABLET, CAPSULE, OR GRANULE CONTAINING DESOGESTREL AND METHOD OF PREPARATION THEREOF | 1995 |
|
RU2160107C2 |
SCHEME FOR GESTAGEN-ANTIGESTAGEN INTAKE | 1998 |
|
RU2215540C2 |
PARACETAMOL AND DOMPERIDONE TABLET WITH FILM COATING | 1995 |
|
RU2153337C2 |
MIRTAZAPINE-CONTAINING ORALLY DECOMPOSING COMPOSITION | 2000 |
|
RU2261098C2 |
HALENIC COMPOSITIONS OF ORGANIC COMPOUNDS | 2005 |
|
RU2384328C2 |
COMBINATION, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT OF PATIENTS SUFFERING WITH DEPRESSION | 1997 |
|
RU2181287C2 |
METHOD OF PREPARATION OF HARD MEDICINAL FORM OF DESMOPRESSIN | 2004 |
|
RU2334505C2 |
Authors
Dates
2003-06-27—Published
1998-04-20—Filed